Atlas Trials

Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects

Clinical trial NCT00972075 · COMPLETED

Trial details

NCT number
NCT00972075
Sponsor
Neurim Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-24 Hour Sleep-Wake DisorderBlindness
Start date
2006-02-01
Primary completion
2007-08-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.